Zinc oxide in anti-acne care: mechanisms and modes of action

1Introduction

Acne vulgaris is a multifactorial condition of the pilosebaceous unit driven by four interlinked processes: proliferation of Cutibacterium acnes (formerly Propionibacterium acnes), excess sebum production, follicular hyperkeratinisation and inflammation ^[3].

Zinc oxide is of interest in acne care because a single mineral ingredient can act on several of these processes at once. Its activity is best understood as the combination of the intrinsic properties of the ZnO particle and the biological effects of the Zn²⁺ ions it releases at the skin surface and within the follicle.

2Local zinc reservoir and ion release

In the acidic, sebum-rich micro-environment of the follicle, ZnO slowly solubilises and releases Zn²⁺ ions. It therefore acts as a local, sustained source of bioavailable zinc rather than delivering a single bolus.

This links ZnO as a material to the well-documented biology of zinc in skin: the particle supplies the ion, and the ion drives most of the downstream anti-acne effects ^[8].

3Antibacterial and anti-biofilm activity against C. acnes

ZnO suppresses C. acnes mainly through the Zn²⁺ ions it releases, which interfere with bacterial membrane integrity and enzyme function.

Beyond reducing bacterial counts, zinc has been shown to interfere with biofilm formation. This is relevant because biofilm is a major contributor to the persistence and antibiotic tolerance of C. acnes ^[1,4].

These effects act on several targets and do not rely on the pathways that classical antibiotics use. This makes ZnO relevant at a time of rising antibiotic resistance in C. acnes ^[6].

4Sebum regulation via 5α-reductase inhibition

Zinc ions inhibit type I 5α-reductase, the enzyme in the sebaceous gland that converts testosterone to dihydrotestosterone (DHT) ^[10].

DHT is a key androgenic driver of sebum output, so reducing its local formation can lower sebum production. This addresses one of the root causes of acne, not only its symptoms. It gives ZnO a mild, indirect anti-androgenic and sebum-regulating action, consistent with the clinical improvement seen with zinc salts in inflammatory acne ^[7].

5Anti-inflammatory action

Much of the visible damage in inflammatory acne comes from the host response rather than from the bacteria directly. Zinc dampens this response at several points ^[2]:

• It modulates pro-inflammatory cytokines, such as IL-1, IL-6, TNF-α and IL-8.
• It reduces neutrophil chemotaxis.
• It can downregulate toll-like receptor 2 (TLR2)-mediated signalling in keratinocytes.

Zinc also inhibits bacterial lipase activity, so fewer pro-inflammatory free fatty acids are released from sebum triglycerides. This removes a specific inflammatory trigger within the follicle ^[9].

6Supporting skin properties

ZnO also has mild astringent and sebum-absorbing properties. It supports keratinocyte function and skin-barrier repair, as zinc is an essential cofactor for tissue repair. This can help calm irritated, blemish-prone skin and support the healing of existing lesions.

7Summary

ZnO acts on acne through a reservoir mechanism: the particle delivers Zn²⁺ ions that act against C. acnes, disrupt biofilm, reduce sebum via 5α-reductase inhibition and calm inflammation. It combines several complementary modes of action in one mineral ingredient.

8References

1. Al-Momani H, Massadeh MI, Almasri M, Al Balawi D, Aolymat I, Hamed S, Albiss BA, Ibrahim L, Al Balawi H, Al Haj Mahmoud S. Anti-bacterial activity of green synthesised silver and zinc oxide nanoparticles against Propionibacterium acnes. Pharmaceuticals 2024, 17(2), 255.
2. Brandt S. The clinical effects of zinc as a topical or oral agent on the clinical response and pathophysiologic mechanisms of acne: A systematic review of the literature. Journal of Drugs in Dermatology 2013, 12(5), 542–545.
3. Cervantes J, Eber AE, Perper M, Nascimento VM, Nouri K, Keri JE. The role of zinc in the treatment of acne: A review of the literature. Dermatologic Therapy 2018, 31(1), e12576.
4. Crainic D, Popescu R, Vlad C-D, Serban D-V, Popa D, Popa CA, Toma A-O. Topical zinc oxide nanoparticle formulations for acne vulgaris: A systematic review of pre-clinical and early-phase clinical evidence. Biomedicines 2025, 13(9), 2156.
5. Dréno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Dermato-Venereologica 1989, 69(6), 541–543.
6. Dréno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Effect of zinc gluconate on Propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: In vitro and in vivo study. European Journal of Dermatology 2005, 15(3), 152–155.
7. Dréno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001, 203(2), 135–140.
8. Nair A, Sindhoor SM, Rai SD, Netto G, Mutalik S, Prabhu PP. Metal oxide nanoparticles for acne vulgaris: Mechanisms, synthesis, formulation, and translational prospects. RSC Advances 2026, advance online publication. doi.org/10.1039/d6ra04926e
9. Strauss JS, Stranieri AM. Acne treatment with topical erythromycin and zinc: Effect of Propionibacterium acnes and free fatty acid composition. Journal of the American Academy of Dermatology 1984, 11(1), 86–89.
10. Sugimoto Y, López-Solache I, Labrie F, Luu-The V. Cations inhibit specifically type I 5α-reductase found in human skin. Journal of Investigative Dermatology 1995, 104(5), 775–778.